432 related articles for article (PubMed ID: 28843020)
41. "Atypical" atypical parkinsonism: Critical appraisal of a cohort.
Hirschbichler ST; Erro R; Ganos C; Stamelou M; Batla A; Balint B; Bhatia KP
Parkinsonism Relat Disord; 2017 Apr; 37():36-42. PubMed ID: 28236526
[TBL] [Abstract][Full Text] [Related]
42. Synucleinopathy pathology and REM sleep behavior disorder plus dementia or parkinsonism.
Boeve BF; Silber MH; Parisi JE; Dickson DW; Ferman TJ; Benarroch EE; Schmeichel AM; Smith GE; Petersen RC; Ahlskog JE; Matsumoto JY; Knopman DS; Schenck CH; Mahowald MW
Neurology; 2003 Jul; 61(1):40-5. PubMed ID: 12847154
[TBL] [Abstract][Full Text] [Related]
43. Atypical parkinsonism in Guadeloupe: a common risk factor for two closely related phenotypes?
Lannuzel A; Höglinger GU; Verhaeghe S; Gire L; Belson S; Escobar-Khondiker M; Poullain P; Oertel WH; Hirsch EC; Dubois B; Ruberg M
Brain; 2007 Mar; 130(Pt 3):816-27. PubMed ID: 17303592
[TBL] [Abstract][Full Text] [Related]
44. Incidence of Parkinson's disease and atypical parkinsonism: Russian population-based study.
Winter Y; Bezdolnyy Y; Katunina E; Avakjan G; Reese JP; Klotsche J; Oertel WH; Dodel R; Gusev E
Mov Disord; 2010 Feb; 25(3):349-56. PubMed ID: 20108378
[TBL] [Abstract][Full Text] [Related]
45. Low clinical sensitivity and unexpectedly high incidence for neuropathologically diagnosed progressive supranuclear palsy.
Driver-Dunckley ED; Zhang N; Serrano GE; Dunckley NA; Sue LI; Shill HA; Mehta SH; Belden C; Tremblay C; Atri A; Adler CH; Beach TG
J Neuropathol Exp Neurol; 2023 Apr; 82(5):438-451. PubMed ID: 37040756
[TBL] [Abstract][Full Text] [Related]
46. Familial aggregation of parkinsonism in progressive supranuclear palsy.
Donker Kaat L; Boon AJ; Azmani A; Kamphorst W; Breteler MM; Anar B; Heutink P; van Swieten JC
Neurology; 2009 Jul; 73(2):98-105. PubMed ID: 19458322
[TBL] [Abstract][Full Text] [Related]
47. Macroscopic diagnostic clue for parkinsonism.
Yoshida M; Akagi A; Miyahara H; Riku Y; Ando T; Ikeda T; Yabata H; Moriyoshi H; Koizumi R; Iwasaki Y
Neuropathology; 2022 Oct; 42(5):394-419. PubMed ID: 35996308
[TBL] [Abstract][Full Text] [Related]
48. Magnetic resonance imaging lesion pattern in Guadeloupean parkinsonism is distinct from progressive supranuclear palsy.
Lehéricy S; Hartmann A; Lannuzel A; Galanaud D; Delmaire C; Bienaimée MJ; Jodoin N; Roze E; Gaymard B; Vidailhet M
Brain; 2010 Aug; 133(Pt 8):2410-25. PubMed ID: 20826434
[TBL] [Abstract][Full Text] [Related]
49. New insights into atypical parkinsonism.
Wenning GK; Krismer F; Poewe W
Curr Opin Neurol; 2011 Aug; 24(4):331-8. PubMed ID: 21577106
[TBL] [Abstract][Full Text] [Related]
50. Recent developments in the neuropathological diagnosis of Parkinson's disease and parkinsonism.
Michotte A
Acta Neurol Belg; 2003 Sep; 103(3):155-8. PubMed ID: 14626695
[TBL] [Abstract][Full Text] [Related]
51. Parkinsonism.
Keener AM; Bordelon YM
Semin Neurol; 2016 Aug; 36(4):330-4. PubMed ID: 27643900
[TBL] [Abstract][Full Text] [Related]
52. Lewy bodies in progressive supranuclear palsy represent an independent disease process.
Uchikado H; DelleDonne A; Ahmed Z; Dickson DW
J Neuropathol Exp Neurol; 2006 Apr; 65(4):387-95. PubMed ID: 16691119
[TBL] [Abstract][Full Text] [Related]
53. Topographical differences of brain iron deposition between progressive supranuclear palsy and parkinsonian variant multiple system atrophy.
Han YH; Lee JH; Kang BM; Mun CW; Baik SK; Shin YI; Park KH
J Neurol Sci; 2013 Feb; 325(1-2):29-35. PubMed ID: 23260321
[TBL] [Abstract][Full Text] [Related]
54. Regional brain atrophy in progressive supranuclear palsy and Lewy body disease.
Cordato NJ; Halliday GM; Harding AJ; Hely MA; Morris JG
Ann Neurol; 2000 Jun; 47(6):718-28. PubMed ID: 10852537
[TBL] [Abstract][Full Text] [Related]
55. C9ORF72 intermediate repeat expansion in patients affected by atypical parkinsonian syndromes or Parkinson's disease complicated by psychosis or dementia in a Sardinian population.
Cannas A; Solla P; Borghero G; Floris GL; Chio A; Mascia MM; Modugno N; Muroni A; Orofino G; Di Stefano F; Calvo A; Moglia C; Restagno G; Meloni M; Farris R; Ciaccio D; Puddu R; Vacca MI; Melis R; Murru MR; Tranquilli S; Corongiu D; Rolesu M; Cuccu S; Marrosu MG; Marrosu F
J Neurol; 2015 Nov; 262(11):2498-503. PubMed ID: 26275564
[TBL] [Abstract][Full Text] [Related]
56. Parkinsonism plus syndrome--a review.
Mitra K; Gangopadhaya PK; Das SK
Neurol India; 2003 Jun; 51(2):183-8. PubMed ID: 14570999
[TBL] [Abstract][Full Text] [Related]
57. Milestones in atypical and secondary Parkinsonisms.
Wenning GK; Litvan I; Tolosa E
Mov Disord; 2011 May; 26(6):1083-95. PubMed ID: 21626553
[TBL] [Abstract][Full Text] [Related]
58. [Atypical parkinsonism].
Tysnes OB; Vilming ST
Tidsskr Nor Laegeforen; 2008 Sep; 128(18):2077-80. PubMed ID: 18846125
[TBL] [Abstract][Full Text] [Related]
59. Is Levodopa Response a Valid Indicator of Parkinson's Disease?
Martin WRW; Miles M; Zhong Q; Hartlein J; Racette BA; Norris SA; Ushe M; Maiti B; Criswell S; Davis AA; Kotzbauer PT; Cairns NJ; Perrin RJ; Perlmutter JS
Mov Disord; 2021 Apr; 36(4):948-954. PubMed ID: 33253432
[TBL] [Abstract][Full Text] [Related]
60. Free-water imaging in Parkinson's disease and atypical parkinsonism.
Planetta PJ; Ofori E; Pasternak O; Burciu RG; Shukla P; DeSimone JC; Okun MS; McFarland NR; Vaillancourt DE
Brain; 2016 Feb; 139(Pt 2):495-508. PubMed ID: 26705348
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
